Pusey is new president, GM of WuXiPRA China
China | News | By BioSpectrum Bureau | 0 Comment | 17 Jul, 2013
Singapore: China-based WuXiPRA, a contract research organization (CRO), has appointed Mr James Pusey, as president and g...Read more
What the future holds for the APAC CRO market?
China | Analysis | By BioSpectrum Bureau | 2 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Right on time with the soon expected registrations of the joimax products in Brazil - one of the most emergi...Read more
Eli Lilly, Strides expand in emerging markets
China | News | By BioSpectrum Bureau | 0 Comment | 06 Dec, 2012
Bangalore: Eli Lilly and Company and Strides Arcolab have entered into a collaboration to expand delivery of cancer med...Read more
China will overtake Japan in R&D spending: Report
China | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2013
Singapore: China's biomedical sector is rapidly transforming itself from a manufacturing base to an innovation hub, inve...Read more
Hongquan Liu is new CEO of Simcere
China | News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2012
Singapore: Simcere Pharmaceutical, a leading pharmaceutical company specializing in the development, manufacturing, and ...Read more
BMS, Simcere to develop, sell arthritis drug in China
China | News | By BioSpectrum Bureau | 0 Comment | 21 Jun, 2013
Singapore: Bristol-Myers Squibb (BMS) and China's Simcere Pharmaceutical have expanded their strategic relationship for...Read more
Perceptive opens customer care office in China
China | News | By BioSpectrum Bureau | 0 Comment | 11 Dec, 2012
Singapore: Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International, ha...Read more
Waters receives CFDA nod for new device
China | Regulatory | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2014
Singapore: In a latest statement, Waters Corporation announced that the Chinese Food and Drug Administration (CFDA) has ...Read more
Scientists confirm that bats are source of SARS
China | News | By BioSpectrum Bureau | 0 Comment | 07 Nov, 2013
Singapore: A group of international scientists have isolated a close relative of the Severe Acute Respiratory Syndrome c...Read more
Ambrx partners with WuXi to advance breast cancer treatement
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: In an effort to advance its breast cancer treatment, Ambrx has now partnered with WuXi PharmaTech and a Chine...Read more
Thermo Fisher opens new facility in China
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Thermo Fisher Scientific, the world leader in serving science, announced the official opening of its new fac...Read more
NYSE gears up to delist China Botanic
China | News | By BioSpectrum Bureau | 0 Comment | 03 Apr, 2013
‎Singapore: China Botanic Pharmaceutical, a developer, manufacturer and distributor of botanical products, bio-pha...Read more
GSK sales reps were trained to offer sexual bribes
China | News | By BioSpectrum Bureau | 0 Comment | 29 Jul, 2013
Singapore: Yet another list of shocking insights into the investigation of British drug maker GlaxoSmithKline's bribery ...Read more
Uscom signs deal to distribute its devices in China
China | News | By BioSpectrum Bureau | 0 Comment | 15 Oct, 2013
Singapore: Australia-based Uscom (Ultrasonic Cardiac Output Monitor) has gained a foothold into the rapidly growing Chin...Read more
WuXi PharmaTech facility gets accreditation
China | News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2013
Singapore: Pharmaceutical, biotechnology and medical device research and development outsourcing company WuXi PharmaTech...Read more
ShangPharma retains J P Morgan as financial advisor
China | News | By BioSpectrum Bureau | 0 Comment | 06 Aug, 2012
Singapore: The independent committee of the ShangPharma's board of directors retained J P Morgan Securities as its finan...Read more
China drug market to reach $315 bn by 2020
China | Analysis | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2013
Singapore: Research and consulting firm GlobalData has pointed out that although various probes into drug pricing and sa...Read more